secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
CIK:        0000315545
Form:       8-K
Filed at:   2024-06-25T23:59:59+00:00
Accession:  0001493152-24-025080
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Provectus redeems 11.4M Series D shares for 1.14M Series D-1 shares; authorized share counts amended
--------------------------------------------------------------------------------

- VP and President Dominic Rodrigues forfeits 11,416,262 Series D Preferred shares for 1,141,626 Series D-1 shares.
- Series D authorized shares reduced from 12,374,000 to 957,100; Series D-1 increased from 11,241,000 to 23,042,900.
- Company states new Series D-1 shares are economically equivalent to the forfeited Series D shares.
- Amendments to certificates of designation filed with Delaware Secretary of State on June 24, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/315545/000149315224025080/0001493152-24-025080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/315545/000149315224025080/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-025080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer